Cargando…
P1333: CHEMOTHERAPY-ACTIVATED HSCS ARE DEFINED BY HIGHLY INCREASED MITOCHONDRIAL MASS AND POTENTIAL INDEPENDENT OF CELL CYCLE STATUS
Autores principales: | Sjöberg, Julia, Rydström, Anna, Larsson, Jonas, Enver, Tariq, Mansell, Els, Sigurdsson, Valgardur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430568/ http://dx.doi.org/10.1097/01.HS9.0000972220.45961.19 |
Ejemplares similares
-
MAC-1 marks a quiescent and functionally superior HSC subset during regeneration
por: Rydström, Anna, et al.
Publicado: (2023) -
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
por: Warsi, Sarah, et al.
Publicado: (2022) -
Pyruvate metabolism guides definitive lineage specification during hematopoietic emergence
por: Oburoglu, Leal, et al.
Publicado: (2021) -
Ser1333 phosphorylation indicates ROCKI activation
por: Chuang, Hsiang-Hao, et al.
Publicado: (2013) -
Differentiation latency and dormancy signatures define fetal liver HSCs at single cell resolution
por: Ishida, Takashi, et al.
Publicado: (2023)